sprite-preloader
Dienstag, 02.09.2014 Börsentäglich über 12.000 News von 486 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von AFX News

ZeitAktuelle NachrichtenBewertungLeser
16:07Compuware Agrees To Be Taken Private By Thoma Bravo For About $2.5 Bln-
15:58Actavis Reports FDA Acceptance For Filing Of NDA For Eluxadoline-
15:47ADM To Sell Chocolate Business To Cargill For $440 Mln; 90 Hazleton Jobs To Go1
15:46nykredit - BNP Paribas Primary New Issues : Stabilisation Notice2
15:43Cloud Peak Energy Cuts 2014 Shipment And Adj. EBITDA Guidance1
15:29Halliburton Reaches Settlement On Claims Related To Macondo Well Incident1
15:23Middlefield Canadian Income PCC : Net Asset Value(s)1
15:18Futures Pointing To Modestly Higher Open On Wall Street2
15:09Family Dollar Confirms Receipt Of Sweetened Bid From Dollar General2
15:09Darden Raises Q1 Adj. EPS Outlook; Backs FY15 Profit View1
14:55FDA Grants Orphan Drug Status To Arena's PAH Drug APD8111
14:54Teva's Reslizumab Shows Reduction In Asthma Exacerbations In Clinical Studies4
14:54Brookdale Senior Living, HCP Close Multiple-element Transaction3
14:49Amgen Submits MAA In Europe For Talimogene Laherparepvec2
14:40Duke Energy, Piedmont Natural Select Dominion To Build 'Atlantic Coast Pipeline'1
14:38Amgen Files MAA To EMA For Investigational Medication Evolocumab1
14:33Stillwater Canada To Scale Back Activities For Marathon PGM-copper Project2
14:17Gold Turns Lower As Focus Shifts To ECB3
14:13Crude Oil Slides Near $95 On Demand Worries2
14:06Dollar General Sweetens Bid For Family Dollar1
13:55Alliance Trust PLC : Net Asset Value(s)1
13:55Salix Responds To FDA's XIFAXAN 550mg Complete Response Letter3
13:54M&G High Income Investment Trust PLC : AGM Statement1
13:51Select Income To Buy CCIT For $2.5 Bln, To Divest Healthcare Assets1
13:47Alder Regains Rights To Anti-Inflammation Drug Clazakizumab4